Cafcit is a medication commonly used in the treatment of apnea of prematurity in newborns. It contains the active ingredient caffeine citrate, which works by stimulating the central nervous system and respiratory drive, helping to reduce the number of apnea episodes in premature infants.

Cafcit is typically administered intravenously or orally, and the dosage is carefully monitored by healthcare professionals to ensure optimal effectiveness and safety. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider.

While Cafcit is generally well-tolerated, some common side effects may include irritability, restlessness, and increased heart rate. In rare cases, more serious side effects such as seizures or allergic reactions may occur. It is important to notify your healthcare provider immediately if you experience any concerning symptoms while taking Cafcit.

As with any medication, it is important to discuss the potential risks and benefits of Cafcit with your healthcare provider before starting treatment. They can provide personalized recommendations based on your individual medical history and needs.

Overall, Cafcit can be a valuable tool in the management of apnea of prematurity in newborns, helping to improve respiratory function and overall health outcomes. By working closely with your healthcare team and following their guidance, you can help ensure the safe and effective use of Cafcit for your child.